Members of the Senate advanced legislation on Wednesday that seeks to expand the pool of federally licensed entities permitted to grow marijuana for clinical research purposes. For over five decades, federal regulators have only authorized a single licensee – the University of Mississippi – to cultivate cannabis plants for use in FDA-approved clinical studies.

The legislation, Senate Bill 2032: The Cannabidiol and Marihuana Research Expansion Act, tasks the US Attorney General with authorizing scientists to engage in marijuana-specific clinical research trials, and also provides the AG with the power to approve applications form multiple entities to “manufacture marijuana for research purposes.” Under the proposal, the AG’s office would need to act upon pending manufacturing applications within 60 days of receiving them. Read the full story HERE